News

New Merck office boasts ‘future-proof’ technology

Merck has unveiled its new Sydney office at an official opening in the ‘innovation hub’ of Macquarie Park. The company joins 180 large international and 200 small businesses in the Macquarie Park Innovation District. The move to 11 Talavera Road is aimed at furthering Merck’s growth, capabilities and business partnerships …

Read More »

Muscle mass linked to healthy hearts in men

Researchers have found that lean muscle mass plays more of a crucial role throughout someone’s middle-age than initially suspected. The amount of lean muscle mass a person has, more specifically men, is linked to their future risk of heart disease. The Journal of Epidemiology and Community Health explains that muscular tissue …

Read More »

Stigma hindering use of naloxone for overdoses

La Trobe University researchers have found that the stigma related to illicit drug use is preventing some people from accessing life-saving overdose medicine, naloxone. La Trobe Professor Suzanne Fraser says naloxone is proven to reverse the effects of an overdose, yet many people are either unaware of how to obtain …

Read More »

The over-60s should do more exercise, not less

To prevent heart disease and stroke, people aged over 60 should do more exercise, not less, according to findings from a study published in the European Heart Journal. Researchers in South Korea studied more than 1.1 million people aged 60 and above and found those who reduced levels of moderate …

Read More »

Digital health strategy progress ‘significant’

Significant progress, state and territory support and a start on implementation are being claimed in the 2018-19 Australian Digital Health Agency (ADHA) annual report. The report, tabled in federal parliament this week, outlines the agency’s outcomes and operations in the year to June 30, 2019. ADHA CEO Tim Kelsey said …

Read More »

TGA approves Mayzent for SPMS ‘unmet need’

The Therapeutic Goods Administration has approved Mayzent for the treatment of adults with secondary progressive multiple sclerosis (SPMS), says Novartis. The registration addresses a critical unmet need, the company says, and makes Mayzent (siponimod) the first and only approved oral treatment for adults with SPMS in Australia. The condition follows …

Read More »

Climate change threat to future health is growing

The mounting risks to human health in Australia due to climate change require urgent government action, say the authors of the 2019 MJA-Lancet Countdown report. The report, published in the Medical Journal of Australia (MJA), found that although some progress has been achieved in renewable energy generation – including substantial employment …

Read More »

Antibiotics mix can cut superbug deaths: study

Patients treated with antibiotic combination therapy were significantly less likely to die than those treated with a single antibiotic, say the authors of a new study. The results of the study, a collaboration between Monash University’s Institute of Pharmaceutical Sciences (MIPS) and the University of North Carolina, could change the …

Read More »

Cannabis drug of choice for endometriosis relief

One in eight Australian women with endometriosis use cannabis to alleviate pain and other symptoms, ranking it as the most effective treatment, according to a new study published this week. Researchers from NICM Health Research Institute, Western Sydney University and UNSW Sydney surveyed 484 Australian women with endometriosis between the …

Read More »

Suicide prevention programs for 2020

The Pharmacy Guild of Australia Queensland Branch has partnered with Australian mental health and suicide prevention social enterprise ConNetica to deliver free, early suicide prevention training programs in 2020. The integrated training programs, ‘Conversations for life’ and ‘Stronger smarter yarns for life’, will be available to community pharmacy staff and …

Read More »